United States

Laboratory Corporation of America Holdings (LH.N)

LH.N on New York Stock Exchange

15 Nov 2018
Change (% chg)

$0.43 (+0.26%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug... (more)


Beta: 1.02
Market Cap(Mil.): $16,592.00
Shares Outstanding(Mil.): 100.90
Dividend: --
Yield (%): --


  LH.N Industry Sector
P/E (TTM): 18.28 39.05 29.53
EPS (TTM): 8.99 -- --
ROI: 6.28 7.08 13.00
ROE: 13.89 0.44 14.69

UPDATE 1-Eurofins Scientific raises outlook after acquisitions, Q3 growth

Oct 23 Luxembourg-based food and biopharma product testing firm Eurofins Scientific raised its earnings expectations for 2019 and 2020 for the second time this year on Tuesday following acquisitions and a strong third quarter.

Oct 23 2018

Pennsylvania insurer, LabCorp defeat lawsuit by rival lab

A federal judge has dismissed a lawsuit by a lab-testing company alleging that a health insurer and Laboratory Corporation of America Holdings worked to eliminate competition for the testing of sexually transmitted diseases in parts of Pennsylvania.

Oct 10 2018

Earnings vs. Estimates